Clinical Development
The latest news about Clinical Development: headlines, AI summaries and the full story from every source.
- CytoDyn Secures $5 Million Private Placement for Leronlimab Development
- Atea Pharmaceuticals Secures $200M Hercules Facility to Extend Cash Runway into Mid-2028
- Xenon Pharmaceuticals Advances Azetukalner Regulatory Path and Announces X-FIRST Study Timeline
- CytomX Therapeutics Projects Varseta-M Registrational Study for First Half of 2027
- OnKure Therapeutics Reports Q3 GAAP EPS of -$0.36 and Strong Cash Runway
- Acadia Pharmaceuticals Reports Q3 2026 Revenue Growth Driven by DAYBUE and NUPLAZID
- Nuvation Bio Reports Q3 2026 Revenue of $45 Million Driven by IBTROZI Growth
- DBV Technologies Projects Cash Runway Through Q3 2027 Amid FDA BLA Filings for VIASKIN
- Kiniksa Pharmaceuticals Raises 2026 Revenue Guidance Following Strong ARCALYST Growth
- Vir Biotechnology Appoints David Liu as Chief Medical Officer
- CSL Enters $1.6 Billion Deal with Alentis Therapeutics for Experimental Kidney and Liver Drug
- Surrozen Receives FDA Clearance to Begin Clinical Development of DME Treatment
- Addex (ADXN) Reports Q2 2026 Financials and Provides Clinical Development Updates
- Gossamer Bio Secures Up to $250M Financing for Seralutinib Development
- BetterLife Pharma Appoints Chief Medical Officer to Lead Migraine Drug Development
- InflaRx Announces Q2 2026 Earnings Release Date
- Ractigen Therapeutics Secures Over $31 Million to Advance saRNA Pipeline
- Summit Therapeutics Outlines FDA PDUFA Date for Ivonescimab BLA on November 14 and Plans HARMONi-3 PFS in Late 2026
- Bone Biologics Provides Mid-Year Shareholder Update on 2026 Progress
- Spero Therapeutics Secures $105 Million Royalty Financing for SP001 Development
- Bristol-Myers Squibb Partners with Anthropic to Expand AI Capabilities